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Abstract 
Bariatric surgery has been considered one of best treatments for obesity. As every surgical procedure—and any 
medical intervention, it is not exempt of complications, among which leaks, strictures, acute hemorrhages and 
fistulae highlight. Leaks are more common in the gastro-jejunal anastomosis (GJA) in the case of Roux-en-y Gastric 
Bypass (RYGB), while in Sleeve Gastrectomy (LSG) they locate in the stapler line. Stenosis can be seen in the gastro-
jejunostomy in the RYGB and in the gastric tube in case of the LSG. For each of these complications, many innova-
tive solutions have been developed, including new surgical devices. In spite of promising good results, evidence 
regarding utility and safeness of these technologies is still scarce. Self-expandable endoscopic stents have been used 
to treat leaks, with an overall success rate of 80–90 % and a migration rate of 15–35 %. The bear trap-like over-the-
scope (Ovesco) clips have been used to treat GI hemorrhages, leaks and even fistulae, with a 70–80 % success rate, 
although more endoscopic sessions may be needed. Overstitch, an endosurgical suture devices, have been used to 
treat leaks, fistulae and perforations. Overall, technical success achievement approaches to 90 %, while clinical success 
ranges from 80 to 90 %, except for leaks closure, where a lower success rate has been observed. Despite of all of these 
advances, early diagnosis and treatment remains the main strategy to achieve success. In summary, novel therapies 
for complication management can be very useful, though further studies with larger series are still needed in order to 
confirm their efficacy and safeness.
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medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons 
license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.
org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Bariatric surgery has become an accepted treatment for 
obesity in the last decades. Obesity and its comorbidities 
can be reasonably treated with many types of bariatric pro-
cedures. Along with obesity prevalence, bariatric surgery 
has increased in number and type. Currently they are one 
of the most frequent elective surgeries performed. Types 
of bariatric procedures are diverse; however, the common-
est are laparoscopic sleeve gastrectomy (LSG), Roux-en-Y 
gastric bypass (RYGB) and adjustable gastric band (AGB). 
Less common are biliopancreatic diversion with duodenal 
switch (BPD-DS) and intragastric balloon (IB).
Complications in bariatric surgery can be observed a 
many stages after the intervention. Mechanisms involved 
seem to have their origins in surgical techniques (based 
on the surgeon’s experience), isquemia, use of drugs and 
the presence of comorbidities. Management of these 
complications have evolved in the last years due to tech-
nology advances to better results, however, as most med-
ical problems, early diagnosis and treatment are still the 
most important prognostic factors.
Bariatric surgery complications
Excepting a few cases, most complications are com-
mon to all bariatric procedures. According to Su-Hsin 
Chang et al. [1] in a systematic review and meta-analysis 
published in JAMA Surgery last year, with more than 
160,000 patients, overall postoperative bariatric compli-
cation rates range from 10 to 17 % and reoperation rates 
approximately 7  %. Nonetheless, mortality still remains 
low, from 0.08 to 0.35 %. Although there are many types 
of complications, Table 1 shows the most frequent ones.
Leaks
Postsurgical leaks can have their origin in gastrojejunal 
anastomosis in the case of RYGB or the staple line in 
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LSG. In the latter case, they can be classified as acute, 
early, late and chronic (<1, 1–6, 6–12 and >12  weeks, 
respectively) [2]. According to most recent evidence, in 
experienced institutions LSG leaks border 1 % incidence 
[3] and according to Parikh et  al. [4] in a systematic 
review and meta-analysis of 9991 patients in 2013, leaks 
rate in a general overview after LSG is 2.2 %. After RYGB, 
it ranges from 1.68 to 2.05 %.
Diagnosis can be challenging and any delay of the treat-
ment worsens patient’s prognosis. Morbidity mostly 
expresses as abdominal pain, taquicardia. Sometimes 
as an abdominal abscess, sepsis or chronic fistula, all 
of which are serious complications that usually lead to 
intensive care units admission, longer hospital stay and 
the development of other medical complications. Risk 
factors associated with postoperative leaks are age, BMI, 
male sex, type 2 diabetes mellitus, obstructive sleep 
apnea syndrome and hypertension [5].
Management of postoperative leaks can be really com-
plex and it can be conservative or invasive depending on 
the patient’s hemodynamic stability and infectious status, 
but as a general rule, life-threatening or chronic events 
require surgical interventions, otherwise conservative 
management is preferred.
As most complications, early diagnosis is critical to 
prevent evolution to general sepsis and peritonitis.
Acute hemorrhages
Hemorrhages usually have their origin in staple line, but 
they can also come from anastomotic or gastric rem-
nant ulcers. In the former case, there is wide agreement 
that oversewing the staple line helps preventing this 
complication.
Patient’s medical history gains importance in this issue 
since comorbidities such as coagulopathies and anti-
hemostatic drugs (warfarin, acenocumarol, ASA) trans-
ports the medical team to a totally different scenario. A 
complete anamnesis is therefore of great importance.
Management consists in conservative support and 
endoscopic interventions in the majority of cases, 
but hemorrhages of big quantity (with hemodynamic 
instability) or from sites inaccessible to endoscope 
require surgical intervention.
Stenosis
Stenosis refers to stricture of an anatomical duct or cav-
ity. Therefore, in bariatric surgery there are several sites 
of possible narrowing, but mainly two: in the RYGB the 
gastrojejunal anastomosis and in LSG the gastric rem-
nant. They develop gradually so they belong to late com-
plications; early strictures in LSG become symptomatic 
hardly before 6 weeks, while in RYGB they do in the late 
third or early fourth week.
Gastrojejunal stenosis is a relative frequent complica-
tion, with incidences varying from 4 to 27 % depending 
on the clinical series described. In the other hand, gas-
tric stenoses border 1 % incidence and their apparition is 
associated with the smaller size of the bougie used.
Clinical manifestations of stenosis include food intoler-
ance, vomiting and dysphagia without abdominal pain. 
Diagnosis can be made through contrasted radiology or 
endoscopy, which can be therapeutic as well. As in other 
cases, management can be conservative, endoscopical or 
surgical.
Bowel obstruction
Bowel obstructions can be early or late, often due to 
internal hernias after gastric bypass in the former case 
and due to intraperitoneal adhesions in the latter. They 
reach 2 and 3 % incidence, respectively. Again, depending 
on patient’s stability and clinical manifestations, a con-
servative treatment can be planned, but surgical manage-
ment is sometimes necessary.
Marginal ulcers
Most marginal ulcers occur within the first 12 months of 
gastric bypass. Their frequency is described up to 16 % of 
patients. Among risk factors is Helicobacter pylori infec-
tion, gastro-gastric fistula, use of NSAIDs, and ischemia.
Management is complex because medical therapy 
does not seem to be effective, surgery has high incidence 
of complications associated and recurrence has been 
reported up to 7.7 %.
Fistulas
Although fistulas can appear along almost any site of 
the digestive tract after surgery, gastro-gastric fistulas 
are particularly worrisome complications after Roux-en-
Y gastric bypass. Incidence has been reported in up to 
1.2 % of cases [6].
Clinical symptoms are mostly related to epigastric 
pain due to ulcerations around the anastomotic site. If 
asymptomatic, they can be managed conservatively at the 
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beginning, but refractory pain and ulcers are the main 
indication for revisional surgery.
Incisional hernia
This type of hernias can appear in any site of abdominal 
incision; however, its frequency in laparoscopic proce-
dures, less than 1 %, differs greatly from open Roux-en-Y 
gastric bypass, around 8 %. Though this kind of interven-
tion is every time less performed, complicated hernias 
have to be kept in mind because complications can come 
up suddenly years after the procedure.
GERD
Gastro-esophageal reflux disease appears in approxi-
mately 12  % of cases after laparoscopic sleeve gas-
trectomy. Management includes dietary and lifestyle 
interventions along with pharmacotherapy, but some-
times revisional surgery is needed, of which gastric 
bypass shows to have the best resolution rate (around 
56 % improvement in symptoms score). It is also neces-
sary to rule out always the presence of hiatal hernia and 
repair it during revisional surgery.
Gastric band complications
Adjustable gastric band is one the commonest proce-
dures among bariatric surgery. Complications are mainly 
band slippage and gastric erosion. The former one causes 
severe dysphagia and vomiting in the early postoperative 
period, while the latter one’s manifestations, which can 
be as serious as GI hemorrhage or intra-abdominal infec-
tions, begin in a later setting.
Diagnosis
As important as being up-to-date with the different diag-
nostic techniques available, is keeping clinical suspicion 
at a low threshold in every patient with a suggestive his-
tory of complications. Therefore, a detailed anamnesis 
and physical examination are crucial in order to detect 
abnormal courses of postoperative evolution. Early diag-
nosis prevents aggressive treatments and in many cases 
revisional procedures that involve high rates of mor-
bidity. Most frequent clinical symptoms and signs are 
abdominal pain, tachycardia, nausea, vomiting, bloating 
and fever. Characteristics of abdominal pain should be 
taken into consideration.
The most frequent diagnostic procedures are contrasted 
studies along with abdominal (with or without pelvic) 
computed tomography. The former ones usually show 
upper GI leaks, fistulas and stenosis, while the latter ones 
detect intra-abdominal collections or intra-peritoneal 
bleeding. Endoscopy in the early postoperative period 
should be avoided, but if necessary it can diagnose and 
treat several complications, such as digestive hemorrhage.
Management
Treatment should always consider, in the appropriate 
conditions, a conservative management. This includes 
adequate hydration, electrolyte homeostasis stabili-
zation, nutritional support, oral or intravenous anti-
biotics, abscess drainage, etc. A correct decision of 
conservative management can avoid unnecessary surgi-
cal interventions, however, if it does not lead to a defini-
tive resolution, it associates with longer hospital stays, 
patient’s discomfort and even the development of chronic 
leaks or fistulas.
Surgery
Surgery is always the most complete procedure since it 
can assess the complete status of the previous surgery, 
and characteristics of the actual anatomy. Laparoscopic 
surgery has gained ground in the last 20 years along with 
all minimal-invasive procedures due to their lower inci-
dence of postoperative infections among other reasons; 
however, it is not exempt of limitations, so the surgeon’s 
experience and surgical feasibility of laparoscopy have 
always to be weighed. Although extremely rare, when 
life-threatening events without clear explanation unex-
pectedly happen, open surgery is indicated.
Self‑expandable endoscopic stents
Self-expandable endoscopic stents (SEES) consist in 
endoluminal prostheses that seek the maintenance of 
digestive tract permeability. Traditionally, they have been 
used to treat benign stenosis and obstructions of neopla-
sic cause. In these cases, stents are usually made of metal, 
but more recently stents made of polyester with an inner 
coverage of silicon have appeared to treat different diges-
tive complications, such as leaks and postoperative stric-
tures. Metal stents have higher friction coefficient with 
digestive mucosa, thus, migration rates are lower than 
polyester ones. On the other hand, stronger fixation of 
metal stents determines greater difficulty in its extraction 
than polyester ones, due to tissue ingrowth under them 
and subsequent adhesion.
In recent years, SEES have been used to treat leaks 
detected after bariatric surgery. The mechanism would 
be to cover the site of the luminal defect, allowing it to 
heal without tissue injury. When they are used to treat 
strictures, stents permit to maintain cavities open, so that 
the healing process (cicatrization and fibrosis) finishes 
with a permeable duct.
Since stents were initially designed to be attached to 
the esophagus, when they are placed in the gastrojejunal 
anastomosis they tend to migrate more frequently.
In general, they are well tolerated. Some patients report 
nausea, dysphagia or discomfort and up to 9  % require 
revision, usually due to persistent leaks or migration. 
Page 4 of 5Hernández and Boza  Ann Surg Innov Res  (2016) 10:3 
Enteral nutrition with liquid diet is mostly well tolerated. 
The clear advantage of this procedure is that this can be 
kept instead of parenteral nutrition with all the complica-
tions it carries.
When a stent fails to prevent leaks, it is not necessary 
to remove it. Instead, a second one can be placed over 
the first one, covering both proximal and distal edges. 
Regardless of this, stents should not remain in its place 
for more than 7 months. In leaks treatment, the highest 
proportion of patients keep it for 6 weeks, enough time 
to allow the wound to heal and not developing excessive 
adhesion to the tissue.
Evidence regarding stent use is scarce. One of the 
meta-analysis available assessed the use of stents postop-
eratively in 67 patients. They reported success in leakage 
management in 87.7  % of cases, migration in 17  % and 
successful extraction in 92 % [7]. In other studies, success 
in leakage management is approximately the same.
According to our experience, despite the long period 
needed to treat, the overall success rate of SEES use was 
96  %. The migration rate was approximately 34  %, with 
the need of repositioning or replacement in the major-
ity of these cases [8]. The experience of Schiesser et  al. 
[2] follows this tendency with an 88  % success, though 
their management included other interventions such as 
Ovesco® clips, discussed later.
Documented experiences in the use of SEES in chronic 
leaks or fistulas are rare and they generally reveal worse out-
comes; recently, Puig et al. published their series with metal 
prostheses where only 4 out of 21 patients could be treated 
exclusively with SEES, though they concluded it may help 
suppress ongoing sepsis and allow patients to undergo oral 
nutrition before definitive surgical resolution [9].
Considering that stents avoid surgery with its morbid-
ity and mortality, it is still an option that can be measured 
among others and a recent expert consensus considers it 
a valid option [10].
Over‑the‑scope clips
This kind of endosurgical clips was recently introduced 
to treat GI hemorrhages and perforations. It consists in 
an applicator cap, a hand wheel and the clip. The appli-
cator cap has three different diameters to fit in different 
endoscopes. The clips look like a bear trap, so they apply 
pressure equally in a circumference form. There are three 
different kinds of clips: one with blunt teeth and two with 
sharp teeth that differ from each other in their length. 
Blunt teeth clips are more often used to control bleeding, 
while the sharp ones are used to close perforations or to 
manage indurated, fibrotic tissue (usually associated with 
chronic injury).
To use this device it has to be fitted on the tip of the 
endoscope fixed over the applicator cap that incorporates 
a release thread which is passed through the working 
channel and connected to a turning wheel mounted on 
working channel access port. The main difference with 
other endosurgical clips is that in this case pressure is 
applied in a circumference form. They should not be used 
in sites adjacent to collections or infections.
As in other novel treatments, evidence is scarce. There 
have been cases reported with successful management of 
gastrointestinal or gastrocutaneous fistulas. The experi-
ence of Surace et al. with the biggest series reported, 19 
patients with GI fistula showed a 74 % success [11].
Keren et  al. [12] reported recently an 80  % success in 
treating postoperative leaks after LSG, in a series of 26 
patients, with a median of three endoscopic sessions and 
no complications related to the procedure.
Overstitch
The Overstitch system consists in a single-use endosur-
gical suture device which is attached to the endoscope 
and allows deploying various stitches in a relatively small 
working space. The curved needle design allows for con-
trolled depth of suture placement and enables the place-
ment of durable full-thickness stitches. It is capable of 
deploying and reloading sutures while maintaining direct 
visualization of the operative site, for better control and 
minimal scope insertions and removals.
The utility of this novel endoscopic suture system is 
that it can resolve several bariatric surgery complica-
tions: outlet and puch reduction, fistula closures, gas-
tric placation and even GI bleeding. Evidence regarding 
Overstitch’s utility is scarce, being published mainly 
case reports. In one of the latest and biggest series ever 
published, Sharaiha et  al. analyzed retrospectively 122 
patients from eight different centers who were treated 
with Overstitch suturing system due to different causes, 
namely, fistulas, leaks, perforations and stent anchorage. 
A 97.5  % overall technical success was achieved, while 
clinical success for stent anchorage, perforations and 
anastomotic leak closure was 91.4, 93, 80 and 27 % [13].
Stomaphyx
The Stompahyx system was created with the purpose of 
gastric plication. It places full-thickness polypropylene 
fasteners through the gastric mucosa, which is previously 
drawn into the device’s chamber by suction. The fasteners 
are not absorbable and are firm enough to maintain gas-
tric plications. It can be used to reduce the gastric pouch 
or stoma in patients that have regained weight, but it can 
also be used to repair leaks in the GI wall.
Evidence regarding efficacy of Stomaphyx is scarce. 
Goyal et al. made a retrospective analysis of 53 patients 
post gastric bypass who underwent gastric pouch reduc-
tion with Stomaphyx, which showed EWL not sustained 
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over time [14]. Consistently, the only randomized con-
trolled trial comparing Stomaphyx with a sham endo-
scopic procedure in patients post RYGB with weight 
regain, performed by Eid et  al. demonstrated clinically 
significant reduction in regained weight in only 22.2  % 
of participants, though this difference was significant 
with 3.4 % of sham procedure patients group [15]. Thus, 
Stomaphyx is a reasonable alternative in patients with 
weight regain in which the risks of a second surgery 
would exceed the benefits of weight loss, considering its 
limited reach.
Endoscopic dilators
Stenosis after bariatric surgery has been traditionally 
treated with surgery or balloon dilation. Nowadays, 
Savary–Gilliard are the most widely used dilators in 
treating this condition. They consist in polyvinyl tubes 
with different diameters (5–20 mm) with a radio-opaque 
band to aid radiological localization. Benign and malig-
nant esophageal stenosis can be resolved by this device, 
however, in bariatric surgery its utility is focused mainly 
in gastric stenosis post sleeve gastrectomy and anasto-
motic stenosis after Roux-en-Y gastric bypass.
Available evidence shows that anastomotic strictures 
can be resolved in around 75 % of cases through Savary-
Gilliard dilators, with low morbidity and no mortality 
associated.
Conclusion
Complications are the source of mortality after Bariatric 
Surgery. Early diagnosis and treatment remain the most 
important step to achieve good results. Novel treatments 
of complications have evolved to the arena of endoscopy. 
Any of these treatments should be indicated as soon as 
possible to promote better results. There has been lim-
ited results for chronic complications.
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